📢 Fellows and trainees: Don’t miss your chance to present at the 2025 GRAPPA Annual Meeting in Bogotá, Colombia! Share your research with global experts, gain recognition, and have your travel covered if selected. Submit your abstract today: 🔗

This research highlights the need for standardized outcomes. Read more 🔗

Calling all junior faculty and trainees! @GrappaO is funding pilot projects on psoriasis and psoriatic arthritis. Apply today to: 🔬 Secure funding for your innovative research. 🌐 Connect with a global network of experts. 💡 Advance care 🔗

Hear Dr. Bruce Strober and Dr. Guy Eakin discuss journal indexing and the future of JPPA in our latest episode of #PsoundBytesPro 🔗

New research published the in #JPPA finds a higher prevalence of femoral atherosclerotic plaque in psoriasis patients compared to controls, highlighting the importance of screening for cardiovascular comorbidities. Learn more about key risk factors:

Last weekend Guy Eakin, Ph.D., represented NPF at #PPACMAN2024. He shared updates on advancing our Strategic Plan, highlighted CDC-funded public health work, and presented the NPF Health Indicator Report to top clinical experts!

A new survey published in the #JPPA highlights the gap between patient treatment goals and satisfaction for #psoriasis and #psoriaticarthritis. Low satisfaction underscores the need for better patient-healthcare provider communication. Learn more:

Learn more about how real-world evidence like this is vital to understanding psoriasis beyond clinical care in the latest issue of the #JPPA 💡

New research in the Journal of Psoriasis and Psoriatic Arthritis® highlights that most patients initiating systemic therapy meet @IpcPs severity criteria, though PASI scores & BSA alone may miss some candidates. Learn more about these findings:

RT @Amgen: This #HealthySkinMonth, let’s talk about plaque #psoriasis. It is not just a skin condition—it is a systemic disease. @NPF’s J…

Clinical trials for palmoplantar pustulosis (PPP) often rely on clinician-reported outcomes. A study in the JPPA found more focus on patient perspectives—pain, itch, quality of life—is needed for a comprehensive view of treatment impact. 🔗

Know a healthcare professional making strides in psoriatic disease care and research? Nominate them for the 2025 NPF Medical Professional Awards! Submit your nomination and help honor those making a lasting impact. #dermtwitter #medtwitter #rheumtwitter

💡 Generalized pustular psoriasis (GPP) poses diagnostic challenges, with variable prevalence worldwide. Key insights from a study in the JPPA shows IL-36 drives the disease, and new treatments like spesolimab target this pathway. Learn more:

📊 New study in the JPPA highlights the need for enhanced communication between #psoraisis patients and #healthcareproviders to align treatment goals and expectations and to improve treatment satisfaction and disease management. Learn more 💡

📢 Exciting Milestone for Psoriatic Disease Research! We are excited to announce our Journal of Psoriasis and Psoriatic Arthritis® has been accepted for indexing on PubMed, a major step forward in amplifying psoriatic disease-specific research. Learn more:

Findings from our Health Indicator Report show that over one-third of psoriasis patients report never being asked about pain and itch—two of the most bothersome symptoms. 🩺 Read more about the findings and the importance of addressing these symptoms.

Know a healthcare professional making strides in psoriatic disease care and research? Nominate them for the 2025 NPF Medical Professional Awards! Submit your nomination and help honor those making a lasting impact. #dermtwitter #medtwitter #rheumtwitter

Happy #InternationalPodcastDay! We are proud to bring you stories, #treatment updates, guidance on managing #psoriaticdisease, and so much more with #PsoundBytesCME for providers treating psoriatic disease. Listen and learn: